Optimizing Ex Vivo CAR-T Cell-mediated Cytotoxicity Assay Through Multimodality Imaging
![CAR-T cells, CAR-Target, CD19, CD20, HER2](https://delivery-files.atcc.org/api/public/content/93857-CL-1562_1400x300.jpg)
Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
San Diego, California, United States
November 03, 2023Abstract
Download the poster to explore our data on the optimization of a CAR-T cell-mediated cytotoxicity assay
DownloadWatch the poster presentation
Presenter
John Foulke, MS
Lead Biologist, ATCC
John Foulke is a Lead Biologist in the Immuno-Oncology group in the R&D department at ATCC. John joined the ATCC cell biology R&D group in 2008, and he has led many projects centered on the development of novel cell lines and cell-based reporter systems to support cancer research community. His work is mainly focused on developing innovative cell models for research and drug discovery in the immuno-oncology field.